Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,568 | 439 | 55.2% |
| Gift | $6,721 | 1 | 35.1% |
| Travel and Lodging | $1,648 | 6 | 8.6% |
| Education | $212.07 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NxThera, Inc. | $6,804 | 4 | $0 (2018) |
| COLOPLAST CORP | $1,414 | 31 | $0 (2024) |
| Axonics, Inc. | $1,352 | 11 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $1,127 | 42 | $0 (2024) |
| Teleflex LLC | $1,067 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $857.47 | 52 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $643.23 | 14 | $0 (2024) |
| Antares Pharma, Inc. | $502.06 | 38 | $0 (2024) |
| ABBVIE INC. | $458.19 | 21 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $418.47 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,904 | 64 | Teleflex LLC ($367.91) |
| 2023 | $2,103 | 72 | Myriad Genetic Laboratories, Inc. ($433.73) |
| 2022 | $2,138 | 72 | Teleflex LLC ($344.81) |
| 2021 | $1,976 | 72 | Axonics, Inc. ($896.66) |
| 2020 | $906.14 | 52 | Coloplast Corp ($238.23) |
| 2019 | $867.17 | 32 | Dendreon Pharmaceuticals LLC ($180.91) |
| 2018 | $1,761 | 52 | Coloplast Corp ($821.40) |
| 2017 | $7,495 | 34 | NxThera, Inc. ($6,750) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: UROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $18.41 | General |
| Category: Urology | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $0.78 | General |
| Category: Urology | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $0.68 | General |
| Category: Urology | ||||||
| 10/31/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: rezum_URO | ||||||
| 10/29/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunotherapy | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: HORMONE THERAPY | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $125.25 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/19/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Women's Health | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Urology | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Oncology | ||||||
| 07/26/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/27/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $164.18 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/27/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $161.24 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/27/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Women's Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 6,342 | 27,017 | $1.4M | $355,901 |
| 2022 | 57 | 7,168 | 25,552 | $1.6M | $424,141 |
| 2021 | 59 | 7,858 | 26,931 | $1.7M | $468,372 |
| 2020 | 62 | 8,523 | 33,596 | $2.7M | $637,061 |
All Medicare Procedures & Services
233 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 809 | 1,073 | $273,991 | $90,187 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 617 | 756 | $129,987 | $46,083 | 35.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,620 | $60,782 | $29,938 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 176 | 176 | $69,106 | $18,479 | 26.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 28 | 128 | $87,419 | $17,238 | 19.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 13 | 2,700 | $34,776 | $13,441 | 38.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 77 | 77 | $63,981 | $13,359 | 20.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 412 | 535 | $36,011 | $9,641 | 26.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 137 | 143 | $52,063 | $8,109 | 15.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 834 | 935 | $14,586 | $7,854 | 53.8% |
| 57288 | Creation of sling around urethra in female to control leakage | Facility | 2023 | 14 | 14 | $24,768 | $7,680 | 31.0% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 15 | 2,160 | $15,079 | $6,490 | 43.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 38 | 43 | $28,278 | $5,213 | 18.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 1,143 | 1,660 | $19,156 | $5,149 | 26.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 138 | 204 | $19,270 | $5,147 | 26.7% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 33 | 73 | $20,914 | $4,539 | 21.7% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 19 | 2,000 | $13,020 | $4,422 | 34.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 13 | 15 | $12,044 | $4,315 | 35.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 26 | 28 | $17,643 | $4,058 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $13,007 | $3,889 | 29.9% |
| 53899 | Other procedure on urinary system | Office | 2023 | 28 | 28 | $21,840 | $3,690 | 16.9% |
| 51705 | Simple change of bladder tube | Office | 2023 | 19 | 54 | $15,184 | $3,677 | 24.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 34 | 34 | $19,649 | $3,291 | 16.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 41 | 41 | $20,762 | $3,112 | 15.0% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 14 | 35 | $11,201 | $2,832 | 25.3% |
About Dr. Brian Roberts, MD
Dr. Brian Roberts, MD is a Urology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700877909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Roberts, MD has received a total of $19,149 in payments from pharmaceutical and medical device companies, with $1,904 received in 2024. These payments were reported across 450 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($10,568).
As a Medicare-enrolled provider, Roberts has provided services to 29,891 Medicare beneficiaries, totaling 113,096 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 233 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Myrtle Beach, SC
- Active Since 11/04/2005
- Last Updated 12/29/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1700877909
Products in Payments
- Rezum (Device) $6,804
- UROLIFT (Device) $862.39
- ALTIS (Device) $786.64
- PROLARIS (Device) $765.08
- PROVENGE (Drug) $643.23
- Bulkamid (Device) $500.62
- BOTOX (Biological) $484.29
- Axonics (Device) $455.23
- XIAFLEX (Biological) $432.34
- Axonics r-SNM System (Device) $396.04
- XTANDI (Drug) $362.78
- ORGOVYX (Drug) $358.59
- MYRBETRIQ (Drug) $315.69
- Nubeqa (Drug) $265.69
- LYNPARZA (Drug) $243.42
- GEMTESA (Drug) $240.16
- UroLift System (Device) $209.01
- NOCDURNA (Drug) $205.85
- Axumin (Drug) $189.84
- ZYTIGA (Drug) $179.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Myrtle Beach
Dr. Neal Shore, Dr, DR
Urology — Payments: $3.7M
Dr. William Bogache, Md, MD
Urology — Payments: $82,917
Dr. Abhishek Srivastava, M.d, M.D
Urology — Payments: $31,006
Dr. Richard Young, Dr, DR
Urology — Payments: $11,015
Dr. Kenneth Krzyzaniak, Md, MD
Urology — Payments: $8,180
Dr. Lauren Cooley, M.d, Ph.d, M.D, PH.D
Urology — Payments: $4,468